Danazol (Danocrine), as an effective therapeutic drug, is widely used in clinical practice. When patients are treated with danazol, they may experience some drug side effects, which may have a certain impact on the patient's physical health and treatment effect. The following is a detailed introduction.
Danazol is clinically commonly used to treat endometriosis, fibrocystic breast disease, and hereditary angioedema. Some adverse drug reactions may occur during medication. The common adverse reactions are:
Androgen-like adverse reactions include weight gain, acne, and seborrhea. Clitoral hypertrophy is rare.
Menstrual disorders include breakthrough bleeding, changes in menstrual cycle, and amenorrhea.
Flushing, sweating, vaginal dryness, irritation, and breast shrinkage.
Abnormalities in semen volume, viscosity, sperm count, and sperm motility.
Including elevated serum enzymes and/or jaundice, etc.
Including glucose tolerance, glucagon, thyroid-binding globulin, etc.
Urticaria, pruritus, nasal congestion.
Headache, tension, and emotional instability, etc.
Gastroenteritis, nausea, vomiting, constipation. Pancreatitis and splenic fibrosis are rare.
Muscle cramps or spasms, pain, joint pain, joint locking, etc. Carpal tunnel syndrome secondary to fluid retention is rare.
Hematuria, prolonged amenorrhea after treatment.
Increased red blood cell and platelet counts, eosinophilia, leukopenia, and thrombocytopenia, etc.
Rashes. Photosensitivity, Stevens-Johnson syndrome, and erythema multiforme are rare.
Increased insulin requirements in diabetic patients, changes in libido, myocardial infarction, palpitations, tachycardia, increased blood pressure, interstitial pneumonia; rare cases of cataracts, gum bleeding, fever, pelvic pain, nipple discharge; after long-term use, rare reports of malignant liver tumors have been documented.

